About
Biovie Inc (NASDAQ:BIVI) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
Apr 14 2026
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
Mar 12 2026
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
Feb 23 2026
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
Feb 12 2026
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting
Financials
Revenue
$0
Market Cap
$10.71 M
EPS
-3.28
Google Übersetzer